Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131486) titled 'Isolation and Structural Identification of Human Anti-PEG Pre-existing Antibodies' on Sept. 3.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Jing'an District Central Hospital Of Shanghai
Condition:
None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-14
Target Sample Size: Observation group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340958
Disclaimer: Curated by HT Syndication....